Phase II multicenter randomized trial to assess the efficacy and safety of first line nivolumab in combination with paclitaxel in subjects with R/M HNSCC unable for cisplatin-based chemotherapy (NIVOTAX): A TTCC study.

Lara Iglesias,Alberto Carral,Marc Oliva Bernal,Javier Martinez-Trufero,Almudena Garcia Castano,Vanesa Gutierrez Calderon,Beatriz Cirauqui,Ana Medina,Virginia Arrazubi,Gema Bruixola, Pedro Perez, Neus Baste Rotllan,Ruth Alvarez,Laura Basterretxea,Jordi Rubio-Casadevall,Javier Caballero Daroqui,Joaquina Martinez-Galan,Julio Jose Lambea-Sorrosal,Edel del Barco,Ricard Mesia

JOURNAL OF CLINICAL ONCOLOGY（2021）

引用 0|浏览37

暂无评分

关键词

paclitaxel,chemotherapy,first line nivolumab,cisplatin-based

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要